Market Pulse44Neutral

Cigna CorporationOpportunity Rank #110(CI) Intrinsic Value & DCF Analysis (2026)

Sector: Healthcare

Current Price

$282.08

Last updated: Jun 23, 2026

Price vs Intrinsic Value

$282.08
Price
$708.90
Intrinsic Value
Undervalued by 151%MOS: $567.12

Fundamental Score

48/100
Bearish

Weighted across 6 signals

Narrative Score

56/100
Improving

No change vs previous

Trend Score

42/100
Weak

As of 2026-06-22

The intrinsic value of Cigna Corporation (CI) is estimated at $708.90 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $282.08, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 6.22% long-term growth rate and an 8.50% discount rate (calculated: 6.78%), reflecting expected future free cash flow and cost of capital.

The intrinsic value of Cigna Corporation (CI) is estimated at $708.90 per share based on a 10-year discounted cash flow (DCF) analysis. At the current price of $282.08, the stock appears undervalued relative to its projected cash flow fundamentals. This estimate assumes a 6.22% long-term growth rate and an 8.50% discount rate (calculated: 6.78%), reflecting expected future free cash flow and cost of capital.

Valuation Details

$708.90
151.31% upside
20% margin of safety: $567.12
Years: 10Growth Rate: 6.22%
Want to create your own valuation? Create a free account.

Capital Efficiency

Average Quarterly ROIC
2.94%
Cost of Capital (estimated)11%
Value StatusUnderperforming Capital

The company is earning below its required return. This may indicate inefficient use of capital or excess cash that isn't being reinvested.

Complete historical ROIC is available with
.

Fundamental Details

48/100
BearishWeighted across 6 signals
DCF Discount
151.3% discount to price
100
FCF Yield
13.4% trailing FCF yield
100
ROIC vs WACC
ROIC 2.9% vs WACC 11.0% (0.3x)
13
Net Debt / FCF
2.3x net debt to FCF
21
Buybacks
Share count shrinking
80
FCF CAGR (5Y)
-1.4% 5Y FCF CAGR (adjusted)
0
Strengths: DCF Discount, FCF Yield. Concerns: ROIC vs WACC, Net Debt / FCF.

Narrative Details

56/100
Improving
Vs 6-Month Baseline:Average (50th pct)Weighted across 6 recent drivers
Trend: StableConfidence: 89%Updated: 49m ago
Sources: 56 (44 News · 12 Analyst)
Drivers(last 30 days)
32 news sentiment+0.4
8 regulatory scrutiny+0.3
2 analyst downgrades-0.0
3 earnings beat+0.0
Guidance raise-0.0
10 analyst reiterations0.0

Trend Details

42/100
WeakAs of 2026-06-22308 daily bars used
3M Relative Strength vs SPY-7.5%
6M Relative Strength vs SPY-7.9%
Distance from 52-Week High-15.6%
Price vs 21 EMA40 · -1.5%
Price vs 50 EMA47 · -0.6%
21 EMA vs 50 EMA58 · +0.9%
3M RS vs SPY22 · -7.5%
6M RS vs SPY29 · -7.9%
Distance from 52W High69 · -15.6%

Investment Coach

Updating... 12d ago
WATCHConfidence: 48%
Thesis
Cigna Corporation's stock is significantly undervalued with an estimated fair value 151.5% above the current price, supported by a healthy free cash flow yield of 12.7%. However, returns are currently trailing the estimated cost of capital, indicating operational challenges.
Key Risk
The key risk is the sustained negative spread between ROIC and WACC, which may impair long-term value creation.
Signals To Watch
  • Monitor whether valuation discount remains above 10%.
  • Track ROIC vs WACC spread for sustained improvement.
  • Follow narrative trend for meaningful shifts in the score direction.
Ask the Coach - Available with
Historical Growth Rates
Free Cash Flow- - -Trend CAGR: 6.22%5 Year CAGR: 3.61%

Free Cash Flow (in millions)

TTM20252024202320222021202020192018201720162015201420132012201120102009200820072006
$9,964$10,813$11,769$13,386$9,951$8,345$11,444$10,535$4,298$4,557$4,487$3,227$2,467$1,246$2,758$1,913$2,043$1,052$1,913$1,604$778

How Intrinziq Estimates Fair Value

Intrinziq estimates Cigna Corporation's intrinsic value using a discounted cash flow (DCF) model based on free cash flow trends and a market-based discount rate. The model projects future cash flows over ten years and discounts them using a market return assumption to estimate fair value.

Cigna CorporationHealthcare

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, employers, government entities, and healthcare providers. Meanwhile, the Cigna Healthcare segment delivers an extensive portfolio of products and services, encompassing medical, pharmaceutical, behavioral health, dental, vision, and health advocacy programs for both insured and self-insured customers. This segment also provides Medicare Advantage, Medicare Supplement, and Medicare Part D plans specifically for seniors, in addition to individual health insurance options available on and off public exchanges. Globally, Cigna Healthcare extends international health coverage and benefits to mobile professionals and employees of multinational organizations. Furthermore, the company issues permanent insurance contracts to corporations, designed to cover the lives of specific employees for funding future benefit obligations. Cigna distributes its various offerings through insurance brokers and consultants, direct sales channels to employers, unions, and individuals, and via both private and public exchanges.